Practical and Pragmatic Usage of T3 in Hypothyroidism
Overview
Overview
Authors
Affiliations
Affiliations
Soon will be listed here.
Abstract
Hypothyroidism is one of the common endocrine disorders encountered in clinical practice. Though thyroxine (T4) remains the treatment of choice in most clinical situations, with the recent introduction of oral triiodothyronine (T3) in South Asian countries, it is important to know about its utility in clinical practice. In this brief communication, we delineate potential clinical indications for T3 therapy, while highlighting possible concerns and caveats.
References
1.
Okosieme O, Gilbert J, Abraham P, Boelaert K, Dayan C, Gurnell M
. Management of primary hypothyroidism: statement by the British Thyroid Association Executive Committee. Clin Endocrinol (Oxf). 2015; 84(6):799-808.
DOI: 10.1111/cen.12824.
View
2.
Kalra S, Verma K, Balhara Y
. Thyro-stress. Indian J Endocrinol Metab. 2017; 21(4):632-633.
PMC: 5477454.
DOI: 10.4103/ijem.IJEM_136_17.
View
3.
Jonklaas J, Bianco A, Bauer A, Burman K, Cappola A, Celi F
. Guidelines for the treatment of hypothyroidism: prepared by the american thyroid association task force on thyroid hormone replacement. Thyroid. 2014; 24(12):1670-751.
PMC: 4267409.
DOI: 10.1089/thy.2014.0028.
View
4.
Kalra S, Kumar A
. Quinary prevention: Defined and conceptualized. J Pak Med Assoc. 2019; 69(12):1765-11766.
View
5.
Millan-Alanis J, Gonzalez-Gonzalez J, Flores-Rodriguez A, Ospina N, Maraka S, Moreno-Pena P
. Benefits and Harms of Levothyroxine/L-Triiodothyronine Versus Levothyroxine Monotherapy for Adult Patients with Hypothyroidism: Systematic Review and Meta-Analysis. Thyroid. 2021; 31(11):1613-1625.
PMC: 8917901.
DOI: 10.1089/thy.2021.0270.
View